Graham Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,989
| Closed | -$71.1K | – | 1404 |
|
|
2024
Q4 | $71.1K | Buy |
1,989
+292
| +17% | +$10.4K | ﹤0.01% | 1148 |
|
|
2024
Q3 | $80.2K | Sell |
1,697
-342
| -17% | -$16.2K | ﹤0.01% | 987 |
|
|
2024
Q2 | $102K | Buy |
+2,039
| New | +$102K | ﹤0.01% | 918 |
|
|
2024
Q1 | – | Sell |
-472
| Closed | -$27.4K | – | 1198 |
|
|
2023
Q4 | $27.4K | Sell |
472
-1,401
| -75% | -$81.3K | ﹤0.01% | 927 |
|
|
2023
Q3 | $59.5K | Sell |
1,873
-1,077
| -37% | -$34.2K | ﹤0.01% | 946 |
|
|
2023
Q2 | $243K | Buy |
+2,950
| New | +$243K | 0.01% | 749 |
|
|
2022
Q3 | – | Sell |
-8,123
| Closed | -$938K | – | 1210 |
|
|
2022
Q2 | $938K | Buy |
+8,123
| New | +$938K | 0.04% | 453 |
|